The effects of neuroleptic and tricyclic compounds on BK(Ca) channel activity in rat isolated cortical neurones

British Journal of Pharmacology

Volumn 121, Issue 8, 1997, Pages 1810-1816

  Lee, K ^a,b   McKenna, F ^a   Rowe, I C M ^a   Ashford, M L J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

BK(Ca) channel; Cerebral cortex; Neuroleptics; Tricyclic compounds

Indexed keywords

AMITRIPTYLINE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; PIMOZIDE; POTASSIUM CHANNEL; POTASSIUM ION; SULPIRIDE; TACRINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL CELL; ARTICLE; BRAIN CELL; CONCENTRATION RESPONSE; CONDUCTANCE; CONTROLLED STUDY; MALE; MOTOR CORTEX; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIDE EFFECT;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; CALCIUM; CEREBRAL CORTEX; MALE; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030791270     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701333     Document Type: Article

References (29)

1. ADELMAN, J.P., SHEN, K.-Z., KAVANAUGH, M.P., WARREN, R.A., WU, Y.-N., LAGRUTTA, A., BOND, C.T. & NORTH, R.A. (1992). Calcium-activated potassium channels expressed from cloned complementary DNAs. Neuron., 9, 209-216.
2. ALFREDSSON, G., SEDVALL, G. & WIESEL, F.-A. (1979). Quantitative analysis of sulpiride in body fluids by high-performance liquid chromatography with fluorescence detection. J. Chromatog., 164, 187-193.
3. BOWMAN, W.C. & RAND, M.J. (1984). Textbook of Pharmacology. Second Edition, p 40.21. Oxford: Blackwell Scientific Publications.
4. CHANGEUX, J.-P., GIRAUDAT, J. & DENNIS, M. (1987). The nicotinic acetylcholine receptor: molecular architecture of a ligand-regulated ion channel. Trends Pharmacol. Sci., 8, 459-465.
5. CREESE, I., BURT, D.R. & SNYDER, S.H. (1976). Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science, 184, 481-483.
6. DEMPSTER, J. (1993). Computer Analysis of Electrophysiological Signals. London: Academic Press.
7. FABIATO, A. & FABIATO, F. (1979). Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J. Physiol. (Paris), 75, 463-505.
8. HUANG, C.L. & RUSKIN, B.H. (1964). Determination of serum chlorpromazine metabolities in psychotic patients. J. Nerv. Ment. Dis., 139, 381-386.
9. KERWIN, R.W. (1994). The new atypical antipsychotics. Br. J. Psychiatry, 164, 141-148.
10. ATP by sulphonylureas in CRIG1 insulin-secreting cells. Br. J. Pharmacol., 111, 632-640.
11. Ca channel activity in rat isolated cortical neurones. J. Physiol., 483, 67P.
12. + channel present in rat cortical neurones. J. Physiol., 488, 319-337.
13. MCCANN, J.D. & WELSH, M.J. (1987). Neuroleptics antagonise a calcium-activated potassium channel in airway smooth muscle. J. Gen. Physiol., 89, 339-352.
14. + channel. Eur. J. Pharmacol., 198, 101-104.
15. + current in rat phaeochromocytoma cells. Br. J. Pharmacol., 116, 2603-2610.
16. NODA, M., TAKAHASHI, H., TANABE, T., TOYOSATO, M., KIKYOTANI, S., FURUTANI, Y., HIROSE, T., TAKASHIMA, H., INAYAMA, S., MIYATA, T. & NUMA, S. (1983). Structural homology of Torpedo californica acetylcholine receptor subunits. Nature, 302, 528-532.
17. OGATA, N. & NARAHASHI, T. (1989). Block of sodium channels by psychotropic drugs in single guinea pig cardiac myocytes. Br. J. Pharmacol., 97, 905-913.
18. + current by chlorpromazine and 4-aminopyridine in neurones of the rat dorsal root ganglia. Br. J. Pharmacol., 109, 1239-1246.
19. OGATA, N., YOSHII, M. & NARAHASHI, T. (1990). Differential block of sodium and calcium channels by chlorpromazine in mouse neuroblastoma cells. J. Physiol., 420, 165-183.
20. 3H] chlorpromazine labels three amino acids of the acetylcholine receptor γ subunit: Implications for the α-helical organization of regions MII and for the structure of the ion channel. Proc. Natl. Acad. Sci. U.S.A., 87, 4675-4679.
21. REYNOLDS, G.P. (1992). Developments in the drug treatment of schizophrenia. Trends Pharmacol. Sci., 13, 116-121.
22. ROBBINS, J. & SIM, J.A. (1990). A transient outward current in NG108-15 neuroblastoma x glioma hybrid cells. Pflugers Arch., 416, 130-137.
23. RODBARD, D. (1974). Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin. Chem., 20, 1255-1270.
24. SEEMAN, P. (1972). The membrane actions of anaesthetics and tranquilizers. Pharmacol. Rev., 24, 583-655.
25. SEEMAN, P. (1980). Brain dopamine receptors. Pharmacol. Rev., 32, 229-313.
26. SEEMAN, P. & VAN TOL, H.H.M. (1994). Dopamine receptor pharmacology. Trends Pharmacol. Sci., 15, 264-270.
27. WHITER, F.J. & WANG, R.Y. (1983). Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science, 221, 1054-1056.
28. WOOLTORTON, J.R.A. & MATHIE, A. (1993). Block of potassium currents in rat isolated sympathetic neurones by tricyclic antidepressants and structurally related compounds. Br. J. Pharmacol., 110, 1126-1132.
29. ZONA, C., TANCREDI, V., PALMA, E., PIRRONE, G.C. & AVOLI, M. (1990). Potassium currents in rat cortical neurons in culture are enhanced by the antiepileptic drug carbamazepine. Can. J. Physiol. Pharmacol., 68, 545-547.